The widespread use of the Prostate Specific Antigen (PSA) blood testing in the U.S. resulted in not only higher prostate cancer incidence, but also a much higher proportion of early stage cases being diagnosed than in countries with lower level of testing that may have led to higher survival rates overall and lower mortality rates relative to incidence [20]. Here, KLK3 is linked to prostate cancer.